Tauxib

Tauxib is a new COX-2 selective inhibitor. Current therapeutic indications are: treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. Like any other COX-2 selective inhibitor, Tauxib selectively inhibits isoform 2 of cyclo-oxigenase enzyme (COX-2). This reduces the generation of prostaglandins (PGs) from arachidonic acid.

Tauxib - Pharmacology:

Like any other COX-2 selective inhibitor Tauxib selectively inhibits isoform 2 of cyclo-oxigenase enzyme (COX-2). This reduces prostaglandins (PGs) generation from arachidonic acid.

Generic name, Overdose, Half Life Tauxib, Food Interactions, Chemical, etc..

Tauxib see also Ashwagandha

Arthritis
Brand Names containing Etoricoxib